• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物群调节先天免疫信号和对癌症的保护性免疫。

Microbiota regulate innate immune signaling and protective immunity against cancer.

机构信息

Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA; Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.

Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.

出版信息

Cell Host Microbe. 2021 Jun 9;29(6):959-974.e7. doi: 10.1016/j.chom.2021.03.016. Epub 2021 Apr 23.

DOI:10.1016/j.chom.2021.03.016
PMID:33894128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8192480/
Abstract

Microbiota play critical roles in regulating colitis and colorectal cancer (CRC). However, it is unclear how the microbiota generate protective immunity against these disease states. Here, we find that loss of the innate and adaptive immune signaling molecule, TAK1, in myeloid cells (Tak1) yields complete resistance to chemical-induced colitis and CRC through microbiome alterations that drive protective immunity. Tak1 mice exhibit altered microbiota that are critical for resistance, with antibiotic-mediated disruption ablating protection and Tak1 microbiota transfer conferring protection against colitis or CRC. The altered microbiota of Tak1 mice promote IL-1β and IL-6 signaling pathways, which are required for induction of protective intestinal Th17 cells and resistance. Specifically, Odoribacter splanchnicus is abundant in Tak1 mice and sufficient to induce intestinal Th17 cell development and confer resistance against colitis and CRC in wild-type mice. These findings identify specific microbiota strains and immune mechanisms that protect against colitis and CRC.

摘要

微生物组在调节结肠炎和结直肠癌(CRC)方面发挥着关键作用。然而,目前尚不清楚微生物组如何产生针对这些疾病状态的保护性免疫。在这里,我们发现髓样细胞中先天和适应性免疫信号分子 TAK1 的缺失(Tak1)通过改变微生物组产生对化学诱导的结肠炎和 CRC 的完全抗性,从而驱动保护性免疫。Tak1 小鼠表现出改变的微生物组,这对于抵抗是至关重要的,抗生素介导的破坏会消除保护作用,而 Tak1 微生物组转移则赋予对结肠炎或 CRC 的保护作用。Tak1 小鼠的改变的微生物组促进了 IL-1β 和 IL-6 信号通路,这是诱导保护性肠道 Th17 细胞和抵抗所必需的。具体而言,Odo ribacter splanchnicus 在 Tak1 小鼠中丰富,足以诱导肠道 Th17 细胞的发育,并赋予野生型小鼠对结肠炎和 CRC 的抵抗能力。这些发现确定了特定的微生物菌株和免疫机制,可预防结肠炎和 CRC。

相似文献

1
Microbiota regulate innate immune signaling and protective immunity against cancer.微生物群调节先天免疫信号和对癌症的保护性免疫。
Cell Host Microbe. 2021 Jun 9;29(6):959-974.e7. doi: 10.1016/j.chom.2021.03.016. Epub 2021 Apr 23.
2
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.可转移免疫球蛋白 A 包裹的内脏欧陆森氏菌在溃疡性结肠炎粪便微生物移植应答者中限制结肠炎症。
Gastroenterology. 2022 Jan;162(1):166-178. doi: 10.1053/j.gastro.2021.09.061. Epub 2021 Oct 2.
3
Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.经口灌胃结直肠癌患者粪便样本可促进无菌和普通小鼠的肠道肿瘤发生。
Gastroenterology. 2017 Dec;153(6):1621-1633.e6. doi: 10.1053/j.gastro.2017.08.022. Epub 2017 Aug 18.
4
Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.结肠炎诱导的结直肠癌和肠上皮雌激素受体β影响肠道微生物多样性。
Int J Cancer. 2019 Jun 15;144(12):3086-3098. doi: 10.1002/ijc.32037. Epub 2019 Jan 11.
5
Diet Modifies Colonic Microbiota and CD4 T-Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-Cell Expression of Interleukin 23.饮食改变结肠微生物群和 CD4 T 细胞库,诱导白细胞介素 23 表达的髓系细胞的小鼠结肠炎发作。
Gastroenterology. 2018 Oct;155(4):1177-1191.e16. doi: 10.1053/j.gastro.2018.06.034. Epub 2018 Jun 15.
6
Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis.先天 PI3K p110δ 调节 Th1/Th17 发育和依赖于微生物组的结肠炎。
J Immunol. 2014 Apr 15;192(8):3958-68. doi: 10.4049/jimmunol.1301533. Epub 2014 Mar 14.
7
TAKing on cancer.抗癌。
Cell Host Microbe. 2021 Jun 9;29(6):851-853. doi: 10.1016/j.chom.2021.05.005.
8
Interaction between microbiota and immunity and its implication in colorectal cancer.肠道微生物群与免疫相互作用及其在结直肠癌中的意义。
Front Immunol. 2022 Jul 29;13:963819. doi: 10.3389/fimmu.2022.963819. eCollection 2022.
9
Exopolysaccharide-Producing Strains with Similar Adhesion Property Induce Differential Regulation of Inflammatory Immune Response in Treg/Th17 Axis of DSS-Colitis Mice.具有相似黏附特性的胞外多糖产生菌株可在 DSS-结肠炎小鼠的 Treg/Th17 轴上诱导炎症免疫反应的差异调节。
Nutrients. 2019 Apr 4;11(4):782. doi: 10.3390/nu11040782.
10
The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.膜结合粘蛋白 Muc1 调节小鼠辅助性 T 细胞 17 细胞应答和结肠炎。
Gastroenterology. 2012 Apr;142(4):865-874.e2. doi: 10.1053/j.gastro.2011.12.036. Epub 2011 Dec 24.

引用本文的文献

1
T17 cells regulate chemokine expression in epithelial cells through C/EBPβ and dictate host sensitivity to colitis and cancer immunity.T17细胞通过C/EBPβ调节上皮细胞中的趋化因子表达,并决定宿主对结肠炎和癌症免疫的敏感性。
Sci Adv. 2025 Aug;11(31):eads3530. doi: 10.1126/sciadv.ads3530. Epub 2025 Aug 1.
2
alleviated liver damage induced by acetaminophen by regulating intestinal microbiota.通过调节肠道微生物群减轻对乙酰氨基酚诱导的肝损伤。
Front Microbiol. 2025 Jul 1;16:1589946. doi: 10.3389/fmicb.2025.1589946. eCollection 2025.
3
The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination.肠道微生物群在mRNA-1273疫苗接种后对SARS-CoV-2体液反应中的作用。
Sci Rep. 2025 Jul 9;15(1):24731. doi: 10.1038/s41598-025-11103-w.
4
Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4 T cell differentiation.肠道微生物群衍生的丁酸盐通过调节CD4 T细胞分化介导靛蓝补充剂的抗结肠炎作用。
Imeta. 2025 Apr 19;4(3):e70040. doi: 10.1002/imt2.70040. eCollection 2025 Jun.
5
Individualized metagenomic network model for colorectal cancer diagnosis: insights into viral regulation of gut microecology.用于结直肠癌诊断的个体化宏基因组网络模型:肠道微生物群生态的病毒调控见解
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf208.
6
soluble dietary fiber alleviates ulcerative colitis through restoration of mucosal barrier and gut microbiota homeostasis.可溶性膳食纤维通过恢复黏膜屏障和肠道微生物群稳态来缓解溃疡性结肠炎。
Front Nutr. 2025 Apr 24;12:1579889. doi: 10.3389/fnut.2025.1579889. eCollection 2025.
7
Odoribacter splanchnicus-A Next-Generation Probiotic Candidate.内脏气味杆菌——下一代益生菌候选菌株
Microorganisms. 2025 Apr 3;13(4):815. doi: 10.3390/microorganisms13040815.
8
Characterization of the gut phageome of Japanese patients with ulcerative colitis under endoscopic remission.内镜缓解期日本溃疡性结肠炎患者肠道噬菌体组的特征分析
J Clin Biochem Nutr. 2025 Mar;76(2):202-209. doi: 10.3164/jcbn.24-173. Epub 2024 Nov 20.
9
Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation.灵芝酸通过调节肠道菌群改善肠道屏障功能来减轻溃疡性结肠炎。
Int J Mol Sci. 2025 Mar 10;26(6):2466. doi: 10.3390/ijms26062466.
10
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.肠道的低剂量照射可提高转移性癌症患者中PD-L1阻断疗法的疗效。
Cancer Cell. 2025 Mar 10;43(3):361-379.e10. doi: 10.1016/j.ccell.2025.02.010.

本文引用的文献

1
Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?结直肠癌中的微生物组:如何从宏基因组学到机制?
Trends Microbiol. 2020 May;28(5):401-423. doi: 10.1016/j.tim.2020.01.001. Epub 2020 Feb 13.
2
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.血清淀粉样蛋白 A 蛋白诱导致病性 Th17 细胞并促进炎症性疾病。
Cell. 2020 Jan 9;180(1):79-91.e16. doi: 10.1016/j.cell.2019.11.026. Epub 2019 Dec 19.
3
FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis.FAM64A 通过正向调控 STAT3 活性促进 Th17 分化和结肠炎相关的癌发生。
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10447-10452. doi: 10.1073/pnas.1814336116. Epub 2019 May 6.
4
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.特定共生菌群可诱导 CD8+T 细胞及抗肿瘤免疫。
Nature. 2019 Jan;565(7741):600-605. doi: 10.1038/s41586-019-0878-z. Epub 2019 Jan 23.
5
Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A.非产毒脆弱拟杆菌(NTBF)的给药可减少细菌驱动的慢性结肠炎和肿瘤的发展,而不依赖于多糖 A。
Mucosal Immunol. 2019 Jan;12(1):164-177. doi: 10.1038/s41385-018-0085-5. Epub 2018 Oct 2.
6
The intestinal microbiome influences checkpoint blockade.肠道微生物组影响检查点阻断。
Nat Med. 2018 Mar 6;24(3):254-255. doi: 10.1038/nm.4511.
7
Moving beyond microbiome-wide associations to causal microbe identification.超越微生物组关联,鉴定因果微生物。
Nature. 2017 Dec 14;552(7684):244-247. doi: 10.1038/nature25019. Epub 2017 Dec 6.
8
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
9
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance.野生小鼠肠道微生物群促进宿主健康并提高抗病能力。
Cell. 2017 Nov 16;171(5):1015-1028.e13. doi: 10.1016/j.cell.2017.09.016. Epub 2017 Oct 19.
10
Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation.共生消化链球菌产生的吲哚丙烯酸可抑制炎症。
Cell Host Microbe. 2017 Jul 12;22(1):25-37.e6. doi: 10.1016/j.chom.2017.06.007.